Komori
Kissei Pharmaceutical (4547) · TargetAdvanced

Human Capital Engagement, DEI and Health Management Targets

First written in FY2024. 2 of 3 entries say "Advanced", first in FY2025. Latest entry: FY2026.

3entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2024AdvancedFY2025 – FY20262024: 120242025: 120252026: 12026
Same theme, other companies
Comprehensive Human Capital KPIs and Investment TargetsA theme 292 companies write about · 1 as a headwind · 294 as a tailwind

The whole theme swung hardest in 2021: 1 of 11 companies on the "Worse" side.

81 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 296 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Perspective Key indicators FY2025 target FY2025 actual FY2026 target Developing and acquiring talent capable of executing the growth strategy Percentage of personnel engaged in research and development At least 20% 22.7% At least 20%  Percentage scoring at or above the core level on the DX literacy score 100% 40.8% 100% Diversifying the workforce and working styles Childcare leave uptake rate among female employees 100% 100% 100%  Stress check participation rate 100% 96.2% 100%」

    The company updated its FY2025 actual results and FY2026 targets for the proportion of personnel engaged in research and development, DX literacy, childcare leave uptake and the stress check participation rate.
  2. FY2025AdvancedAnnual report

    「In the survey scheduled to be conducted during the period of the medium-term management plan "Beyond 80" (FY2025–FY2029), the company aims to achieve an average score of at least 3.30 points for questions related to engagement and job satisfaction through the operation of its personnel and education systems. …Childcare leave uptake among male employees FY2024 actual: 100% FY2025 target: 100%…Stress check participation rate FY2024 actual: 96.8% FY2025 target: 100%」

    The company updated the targets for the Beyond 80 period and its FY2024 actual results, including an average engagement score of at least 3.30 points, a 100% childcare leave uptake rate among male employees, and a 100% stress check participation rate.
  3. FY2024First statedAnnual report

    「In the survey scheduled to be conducted during the next medium-term management plan period, the company aims to achieve an average score of at least 3.30 points for questions related to engagement and job satisfaction through the operation of its personnel and education systems. …Childcare leave uptake among male employees…FY2024 target: at least 80%…Stress check participation rate…FY2024 target: 100%」

    The company has, for the first time, explicitly stated numerical targets with deadlines set during the next medium-term management plan period or in FY2024 for engagement and job satisfaction, childcare leave uptake among male employees, and the stress check participation rate.
Moved together

"Sustainable Growth as a Drug Discovery-Focused R&D Company" moved the same way as this thread, in the same document, in 2 of its 3 moves.

222222★123456
  1. ★This thread
  2. 1Sustainable Growth as a Drug Discovery-Focused R&D Company2×
  3. 2Enhancing and Strengthening a Product Portfolio with Distinctive Features and Competitive Advantages2×
  4. 3Efficient Advancement of Clinical Trials for Development Programs and Early Approval2×
  5. 4Establishing a Competitive Advantage and Securing Sales in the Domestic Prescription Pharmaceutical Market2×
  6. 5Promoting overseas expansion and stabilizing the overseas earnings base2×
  7. 6Expanding into Global Markets Through Out-Licensing of Proprietary Products2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Kissei Pharmaceutical's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Human Capital Engagement, DEI and Health Management Targets | KISSEI PHARMACEUTICAL CO.,LTD. (4547) | Komori